Coverage
-
December 20, 2022
The Second Circuit on Tuesday refused to revive a suit accusing Fresenius of paying nephrologists for patient referrals, finding that the dialysis provider's securities filings already discussed the joint venture acquisitions with doctors that relators alleged were fraudulent, thus blocking the suit under the False Claims Act's public disclosure bar.
1 other articles on this case.
View all »